IMNN Return on Tangible Equity | Imunon, Inc.

Imunon, Inc. (IMNN) Return on Tangible Equity

2026-06-30: Return Tang Equity 131.93%.
2026-03-31: Return Tang Equity 122.19%.
2025-12-31: Return Tang Equity 175.05%.
2025-09-30: Return Tang Equity 127.25%.

Complete source-backed return tang equity history.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	131.93%
2026-03-31	122.19%
2025-12-31	175.05%
2025-09-30	127.25%
2025-06-30	124.15%
2025-03-31	119.50%
2024-12-31	167.78%
2024-09-30	272.02%
2024-06-30	155.87%
2024-03-31	275.53%
2023-12-31	998.37%
2023-09-30	-1020.72%
2023-06-30	-494.61%
2023-03-31	-274.36%
2022-12-31	-256.68%
2022-09-30	-103.38%
2022-06-30	-82.49%
2022-03-31	-82.64%
2021-12-31	-51.34%
2021-09-30	-44.46%
2021-06-30	-45.62%
2021-03-31	-41.79%
2020-12-31	-130.04%
2020-09-30	-130.66%
2020-06-30	-86.25%
2020-03-31	-140.10%
2019-12-31	-137.65%
2019-09-30	-63.19%
2019-06-30	-45.41%
2019-03-31	-51.69%
2018-12-31	-64.88%
2018-09-30	-175.94%
2018-06-30	-139.84%
2018-03-31	-98.11%
2017-12-31	-88.51%
2017-09-30	-890.76%
2017-06-30	-601.54%
2017-03-31	-679.46%
2016-12-31	-591.76%
2016-09-30	-316.51%
2016-06-30	-154.72%
2016-03-31	-180.32%
2015-12-31	-133.55%
2015-09-30	868.50%
2015-06-30	-1964.41%
2015-03-31	2521.33%
2014-12-31	-505.09%
2014-09-30	-206.37%
2014-06-30	-114.18%
2014-03-31	-32.12%
2013-12-31	-26.19%
2013-09-30	-43.14%
2013-06-30	-44.01%
2013-03-31	-65.17%
2012-12-31	-222.63%
2012-09-30	-188.01%
2012-06-30	-170.55%
2012-03-31	-126.16%
2011-12-31	-88.78%
2011-09-30	-123.10%
2011-06-30	-4611.00%
2011-03-31	323.35%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	175.05%
2024-12-31	167.78%
2023-12-31	998.37%
2022-12-31	-256.68%
2021-12-31	-51.34%
2020-12-31	-130.04%
2019-12-31	-137.65%
2018-12-31	-64.88%
2017-12-31	-85.25%
2016-12-31	-591.76%
2015-12-31	-133.55%
2014-12-31	-82.72%
2013-12-31	-26.20%
2012-12-31	-222.63%
2011-12-31	-88.78%
2010-12-31	407.44%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
SOLIGENIX, INC. (SNGX)	United States	$0.008B
EXICURE, INC. (XCUR)	United States	$0.008B	-1.54
Traws Pharma, Inc. (TRAW)	United States	$0.009B	-0.58
Alzamend Neuro, Inc. (ALZN)	United States	$0.009B
Ensysce Biosciences, Inc. (ENSC)	United States	$0.008B	-0.37
InMed Pharmaceuticals Inc. (INM)		$0.008B	-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)	United States	$0.008B
FibroBiologics, Inc. (FBLG)	United States	$0.009B	-0.27
CNS Pharmaceuticals, Inc. (CNSP)	United States	$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)	United States	$0.007B	-0.97